SAN MATEO, Calif. and CAMBRIDGE, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (KRON), a company dedicated to developing small molecule therapeutics that address cancers and other diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback